Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7‐induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota

This study evaluated the effects of Bacillus amyloliquefaciens TL106, isolated from Tibetan pigs’ faeces, on the growth performance, immune response, intestinal barrier function, morphology of jejunum, caecum and colon, and gut microbiota in the mice with enterohaemorrhagic Escherichia coli (EHEC)‐induced intestinal diseases. In all, 40 female C57BL/6J mice were randomly divided into four groups: mice fed a normal diet (Control), mice oral...